Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Liraglutide Drugs Market Growth 2022-2028

  • LP 4891176
  • 76 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Liraglutide Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Liraglutide Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Liraglutide Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Liraglutide Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Liraglutide Drugs market, reaching US$ million by the year 2028. As for the Europe Liraglutide Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Liraglutide Drugs players cover Novo Nordisk, Mylan, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Victoza

Saxenda

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Type 2 Diabetes

Obesity

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novo Nordisk

Mylan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Liraglutide Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Liraglutide Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Liraglutide Drugs by Country/Region, 2017, 2022 & 2028

2.2 Liraglutide Drugs Segment by Type

2.2.1 Victoza

2.2.2 Saxenda

2.3 Liraglutide Drugs Sales by Type

2.3.1 Global Liraglutide Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Liraglutide Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Liraglutide Drugs Sale Price by Type (2017-2022)

2.4 Liraglutide Drugs Segment by Application

2.4.1 Type 2 Diabetes

2.4.2 Obesity

2.5 Liraglutide Drugs Sales by Application

2.5.1 Global Liraglutide Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Liraglutide Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Liraglutide Drugs Sale Price by Application (2017-2022)

3 Global Liraglutide Drugs by Company

3.1 Global Liraglutide Drugs Breakdown Data by Company

3.1.1 Global Liraglutide Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Liraglutide Drugs Sales Market Share by Company (2020-2022)

3.2 Global Liraglutide Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Liraglutide Drugs Revenue by Company (2020-2022)

3.2.2 Global Liraglutide Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Liraglutide Drugs Sale Price by Company

3.4 Key Manufacturers Liraglutide Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Liraglutide Drugs Product Location Distribution

3.4.2 Players Liraglutide Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Liraglutide Drugs by Geographic Region

4.1 World Historic Liraglutide Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Liraglutide Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Liraglutide Drugs Annual Revenue by Geographic Region

4.2 World Historic Liraglutide Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Liraglutide Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Liraglutide Drugs Annual Revenue by Country/Region

4.3 Americas Liraglutide Drugs Sales Growth

4.4 APAC Liraglutide Drugs Sales Growth

4.5 Europe Liraglutide Drugs Sales Growth

4.6 Middle East & Africa Liraglutide Drugs Sales Growth

5 Americas

5.1 Americas Liraglutide Drugs Sales by Country

5.1.1 Americas Liraglutide Drugs Sales by Country (2017-2022)

5.1.2 Americas Liraglutide Drugs Revenue by Country (2017-2022)

5.2 Americas Liraglutide Drugs Sales by Type

5.3 Americas Liraglutide Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Liraglutide Drugs Sales by Region

6.1.1 APAC Liraglutide Drugs Sales by Region (2017-2022)

6.1.2 APAC Liraglutide Drugs Revenue by Region (2017-2022)

6.2 APAC Liraglutide Drugs Sales by Type

6.3 APAC Liraglutide Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Liraglutide Drugs by Country

7.1.1 Europe Liraglutide Drugs Sales by Country (2017-2022)

7.1.2 Europe Liraglutide Drugs Revenue by Country (2017-2022)

7.2 Europe Liraglutide Drugs Sales by Type

7.3 Europe Liraglutide Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Liraglutide Drugs by Country

8.1.1 Middle East & Africa Liraglutide Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Liraglutide Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Liraglutide Drugs Sales by Type

8.3 Middle East & Africa Liraglutide Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Liraglutide Drugs

10.3 Manufacturing Process Analysis of Liraglutide Drugs

10.4 Industry Chain Structure of Liraglutide Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Liraglutide Drugs Distributors

11.3 Liraglutide Drugs Customer

12 World Forecast Review for Liraglutide Drugs by Geographic Region

12.1 Global Liraglutide Drugs Market Size Forecast by Region

12.1.1 Global Liraglutide Drugs Forecast by Region (2023-2028)

12.1.2 Global Liraglutide Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Liraglutide Drugs Forecast by Type

12.7 Global Liraglutide Drugs Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Liraglutide Drugs Product Offered

13.1.3 Novo Nordisk Liraglutide Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Liraglutide Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Liraglutide Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Victoza

Table 4. Major Players of Saxenda

Table 5. Global Liraglutide Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Liraglutide Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Liraglutide Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Liraglutide Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Liraglutide Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Liraglutide Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Liraglutide Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Liraglutide Drugs Revenue by Application (2017-2022)

Table 13. Global Liraglutide Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Liraglutide Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Liraglutide Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Liraglutide Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Liraglutide Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Liraglutide Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Liraglutide Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Liraglutide Drugs Producing Area Distribution and Sales Area

Table 21. Players Liraglutide Drugs Products Offered

Table 22. Liraglutide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Liraglutide Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Liraglutide Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Liraglutide Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Liraglutide Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Liraglutide Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Liraglutide Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Liraglutide Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Liraglutide Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Liraglutide Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Liraglutide Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Liraglutide Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Liraglutide Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Liraglutide Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Liraglutide Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Liraglutide Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Liraglutide Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Liraglutide Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Liraglutide Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Liraglutide Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Liraglutide Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Liraglutide Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Liraglutide Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Liraglutide Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Liraglutide Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Liraglutide Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Liraglutide Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Liraglutide Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Liraglutide Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Liraglutide Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Liraglutide Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Liraglutide Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Liraglutide Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Liraglutide Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Liraglutide Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Liraglutide Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Liraglutide Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Liraglutide Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Liraglutide Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Liraglutide Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Liraglutide Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Liraglutide Drugs

Table 66. Key Market Challenges & Risks of Liraglutide Drugs

Table 67. Key Industry Trends of Liraglutide Drugs

Table 68. Liraglutide Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Liraglutide Drugs Distributors List

Table 71. Liraglutide Drugs Customer List

Table 72. Global Liraglutide Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Liraglutide Drugs Sales Market Forecast by Region

Table 74. Global Liraglutide Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Liraglutide Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Liraglutide Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Liraglutide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Liraglutide Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Liraglutide Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Liraglutide Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Liraglutide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Liraglutide Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Liraglutide Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Liraglutide Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Liraglutide Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Liraglutide Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Liraglutide Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Liraglutide Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Liraglutide Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Liraglutide Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Liraglutide Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novo Nordisk Basic Information, Liraglutide Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Novo Nordisk Liraglutide Drugs Product Offered

Table 94. Novo Nordisk Liraglutide Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Novo Nordisk Main Business

Table 96. Novo Nordisk Latest Developments

Table 97. Mylan Basic Information, Liraglutide Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Mylan Liraglutide Drugs Product Offered

Table 99. Mylan Liraglutide Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Mylan Main Business

Table 101. Mylan Latest Developments

List of Figures

Figure 1. Picture of Liraglutide Drugs

Figure 2. Liraglutide Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Liraglutide Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Liraglutide Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Liraglutide Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Victoza

Figure 10. Product Picture of Saxenda

Figure 11. Global Liraglutide Drugs Sales Market Share by Type in 2021

Figure 12. Global Liraglutide Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Liraglutide Drugs Consumed in Type 2 Diabetes

Figure 14. Global Liraglutide Drugs Market: Type 2 Diabetes (2017-2022) & (K Units)

Figure 15. Liraglutide Drugs Consumed in Obesity

Figure 16. Global Liraglutide Drugs Market: Obesity (2017-2022) & (K Units)

Figure 17. Global Liraglutide Drugs Sales Market Share by Application (2017-2022)

Figure 18. Global Liraglutide Drugs Revenue Market Share by Application in 2021

Figure 19. Liraglutide Drugs Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Liraglutide Drugs Revenue Market Share by Company in 2021

Figure 21. Global Liraglutide Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Liraglutide Drugs Revenue Market Share by Geographic Region in 2021

Figure 23. Global Liraglutide Drugs Sales Market Share by Region (2017-2022)

Figure 24. Global Liraglutide Drugs Revenue Market Share by Country/Region in 2021

Figure 25. Americas Liraglutide Drugs Sales 2017-2022 (K Units)

Figure 26. Americas Liraglutide Drugs Revenue 2017-2022 ($ Millions)

Figure 27. APAC Liraglutide Drugs Sales 2017-2022 (K Units)

Figure 28. APAC Liraglutide Drugs Revenue 2017-2022 ($ Millions)

Figure 29. Europe Liraglutide Drugs Sales 2017-2022 (K Units)

Figure 30. Europe Liraglutide Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Liraglutide Drugs Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Liraglutide Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Americas Liraglutide Drugs Sales Market Share by Country in 2021

Figure 34. Americas Liraglutide Drugs Revenue Market Share by Country in 2021

Figure 35. United States Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Liraglutide Drugs Sales Market Share by Region in 2021

Figure 40. APAC Liraglutide Drugs Revenue Market Share by Regions in 2021

Figure 41. China Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Liraglutide Drugs Sales Market Share by Country in 2021

Figure 48. Europe Liraglutide Drugs Revenue Market Share by Country in 2021

Figure 49. Germany Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Liraglutide Drugs Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Liraglutide Drugs Revenue Market Share by Country in 2021

Figure 56. Egypt Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Liraglutide Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Liraglutide Drugs in 2021

Figure 62. Manufacturing Process Analysis of Liraglutide Drugs

Figure 63. Industry Chain Structure of Liraglutide Drugs

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390